Transgenic Technology: a Validated Approach for Large-Scale Manufacturing
Transgenic technology – as a platform for the production of human
recombinant therapeutics – offers significant advantages with respect to
capital expenditure and cost of goods. For the near future, the transgenic
production of monoclonal antibodies represents an ideal technology for
the basis of a successful biosimilars programme.
By Yann Echelard, William Gavin, Ashley Lawton, Carol Ziomek and Harry Meade at GTC Biotherapeutics Inc (July 2009)
Keywords: Transgenic technology, production, safety, human recominant therapeutics, monoclonal antibodies,